http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1288698-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d50a5d08fff80f620aa6f328cd9bc85e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-16 |
| filingDate | 1986-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1991-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c16c3732ef77bde5b5e1249f66fe6da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82015c28f36228b12ace553d8f5e495d |
| publicationDate | 1991-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1288698-C |
| titleOfInvention | Transdermal anti-anginal pharmaceutical dosage |
| abstract | ABSTRACT NOVEL TRANSDERMAL ANTI ANGINAL PHARMACEUTICAL ABSORPTION DOSAGE UNIT AND PROCESS FOR ITS ADMINISTRATION Novel transdermal nitroglycerin or other anti-anginal pharmaceutical polymer matrix dosage units have been developed which comprise a backing layer, an adjoining layer of a solid polymer matrix in which the pharmaceutical is microdispersed, and a biologically acceptable adhesive poly-mer layer which has dispersed one or more skin permeation enhancers. Novel process of administration of the anti-anginal pharmaceutical using the novel polymer matrix dosage units is also provided. |
| priorityDate | 1985-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 139.